<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en" article-type="correction">
<?release-delay 0|0?>
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">OL</journal-id>
<journal-title-group>
<journal-title>Oncology Letters</journal-title>
</journal-title-group>
<issn pub-type="ppub">1792-1074</issn>
<issn pub-type="epub">1792-1082</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/ol.2026.15639</article-id>
<article-id pub-id-type="publisher-id">OL-32-1-15639</article-id>
<article-categories>
<subj-group>
<subject>Corrigendum</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>[Corrigendum] Proliferation, migration and invasion of triple negative breast cancer cells are suppressed by berbamine via the PI3K/Akt/MDM2/p53 and PI3K/Akt/mTOR signaling pathways</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Liu</surname><given-names>Lili</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Yan</surname><given-names>Jiadong</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Cao</surname><given-names>Ying</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Yan</surname><given-names>Yan</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Shen</surname><given-names>Xiang</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Yu</surname><given-names>Binbin</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Tao</surname><given-names>Li</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Wang</surname><given-names>Shusheng</given-names></name>
</contrib>
</contrib-group>
<pub-date pub-type="collection"><month>07</month><year>2026</year></pub-date>
<pub-date pub-type="epub"><day>06</day><month>05</month><year>2026</year></pub-date>
<volume>32</volume>
<issue>1</issue>
<elocation-id>284</elocation-id>
<permissions>
<copyright-statement>Copyright: &#x00A9; 2026 Liu et al.</copyright-statement>
<copyright-year>2026</copyright-year>
<license license-type="open-access">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.</license-p></license>
</permissions>
</article-meta>
</front>
<body>
<p>Oncol Lett 21: <related-article xmlns:xlink="http://www.w3.org/1999/xlink" related-article-type="corrected-article" vol="21" page="70" id="RA1" xlink:href="10.3892/ol.2020.12331" ext-link-type="doi">70</related-article>, 2021; DOI: 10.3892/ol.2020.12331</p>
<p>Following the publication of the above article, an interested reader drew to the authors&#x2019; attention that the &#x2018;BBM 10 &#x03BC;M/Transwell&#x2019; and &#x2018;Ctrl/Matrigel transwell&#x2019; data panels in <xref rid="f4-ol-32-1-15639" ref-type="fig">Fig. 4C</xref> on p. 6, showing the results of Transwell migration and invasion assays, were apparently identical. Furthermore, upon performing an independent analysis of the data in this paper in the Editorial Office, it came to light that the &#x2018;BBM 20 &#x03BC;M/0 h&#x2019; and &#x2018;BBM 40 &#x03BC;M/0 h&#x2019; data panels for the MCF-7 cell line in <xref rid="f4-ol-32-1-15639" ref-type="fig">Fig. 4B</xref> also contained an overlapping section, such that data which were intended to show the results of differently performed scratch-wound assay experiments had apparently been derived from the same original source.</p>
<p>After having re-examined their original data, the authors have realized that these figure parts contained data which were inadvertently selected incorrectly for <xref rid="f4-ol-32-1-15639" ref-type="fig">Fig. 4</xref>. The revised version of <xref rid="f4-ol-32-1-15639" ref-type="fig">Fig. 4</xref>, now showing the correct data for the &#x2018;BBM 40 &#x03BC;M/0 h&#x2019; data panel for the MCF-7 cell line in <xref rid="f4-ol-32-1-15639" ref-type="fig">Fig. 4B</xref> and the &#x2018;Ctrl/Matrigel transwell&#x2019; data panel in <xref rid="f4-ol-32-1-15639" ref-type="fig">Fig. 4C</xref>, is shown on the next page. Note that the errors made during the assembly of this figure did not affect the overall conclusions reported in the paper. All the authors agree with the publication of this corrigendum. The authors are grateful to the Editor of <italic>Oncology Letters</italic> for allowing them the opportunity to publish this, and also apologize to the readership for any inconvenience caused.</p>
</body>
<floats-group>
<fig id="f4-ol-32-1-15639" position="float">
<label>Figure 4.</label>
<caption><p>BBM inhibits the migration and invasion of triple negative breast cancer cells. Cells were treated with BBM (10, 20 and 40 &#x00B5;M), migration and invasion were tested using (A) wound closure assays (scale bar, 100 &#x00B5;m) and (B) quantified. (C) Transwell and Matrigel transwell assay cell images (scale bar, 100 &#x00B5;m) and (D) quantification of the results. The Ctrl group was untreated cells. Data are presented as the mean &#x00B1; standard deviation (n=3). &#x002A;P&#x003C;0.05, &#x002A;&#x002A;P&#x003C;0.01, &#x002A;&#x002A;&#x002A;P&#x003C;0.001 vs. Ctrl group. BBM, Berbamine; Ctrl, control..</p></caption>
<alt-text>BBM inhibits the migration and invasion of triple negative breast cancer cells. Cells were treated with BBM (10, 20 and 40 &#x00B5;M), migration and invasion were tested using (A) wound closure assays...</alt-text>
<graphic xlink:href="ol-32-01-15639-g00.jpg"/>
</fig>
</floats-group>
</article>
